China Pharma Holdings (CPHI) FCF Margin (2010 - 2026)
China Pharma Holdings (CPHI) posted FCF Margin of 5.62% for Q1 2026, down 145.48% on a QoQ basis from 12.36% in Q4 2025, and up 600.0% year-over-year from 0.8% in Q1 2025.
China Pharma Holdings (CPHI) FCF Margin (2010 - 2026) Analysis & Trends
China Pharma Holdings' FCF Margin history runs 17 years deep, the most recent figure standing at 5.62% for Q1 2026.
- Quarterly FCF Margin rose 600.0% year-over-year to 5.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.15% (up 329.0% YoY) and the FY2025 annual result came in at 2.15%, up 1196.0% from the prior year.
- FCF Margin was 5.62% for Q1 2026 at China Pharma Holdings, down from 12.36% in the prior quarter.
- Across five years, FCF Margin topped out at 52.11% in Q3 2023 and bottomed at 72.04% in Q1 2023.
- A 5-year average of 8.44% and a median of 5.62% in 2026 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin tumbled 5955 bps — and 2023, when it soared 5381 bps.
- China Pharma Holdings' FCF Margin stood at 20.95% in 2022, then plunged by 106 bps to 1.25% in 2023, then soared by 2071 bps to 24.62% in 2024, then sank by 50 bps to 12.36% in 2025, then slumped by 145 bps to 5.62% in 2026.
- Business Quant data shows CPHI's FCF Margin at 5.62% in Q1 2026, 12.36% in Q4 2025, and 31.42% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | -5.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.62% |
| Dec 31, 2025 | 12.36% |
| Sep 30, 2025 | -31.42% |
| Jun 30, 2025 | 29.93% |
| Mar 31, 2025 | -11.62% |
| Dec 31, 2024 | 24.62% |
| Sep 30, 2024 | -3.43% |
| Jun 30, 2024 | -7.86% |
| Mar 31, 2024 | -42.72% |
| Dec 31, 2023 | -1.25% |
| Sep 30, 2023 | 52.11% |
| Jun 30, 2023 | -19.30% |
| Mar 31, 2023 | -72.04% |
| Dec 31, 2022 | 20.95% |
| Sep 30, 2022 | -1.70% |
| Jun 30, 2022 | -31.56% |
| Mar 31, 2022 | -54.91% |
| Dec 31, 2021 | -7.10% |
| Sep 30, 2021 | -43.81% |
| Jun 30, 2021 | 27.99% |